Inlet Private Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-19,530
Closed -$498K 137
2025
Q3
$498K Hold
19,530
0.11% 106
2025
Q2
$473K Sell
19,530
-100
-0.5% -$2.33K 0.12% 106
2025
Q1
$497K Sell
19,630
-16,478
-46% -$431K 0.13% 102
2024
Q4
$958K Sell
36,108
-10,100
-22% -$274K 0.25% 85
2024
Q3
$1.34M Sell
46,208
-14,035
-23% -$409K 0.34% 76
2024
Q2
$1.69M Sell
60,243
-2,201
-4% -$60.6K 0.46% 64
2024
Q1
$1.73M Sell
62,444
-6,616
-10% -$184K 0.48% 62
2023
Q4
$1.99M Sell
69,060
-5,131
-7% -$155K 0.61% 54
2023
Q3
$2.46M Sell
74,191
-16,843
-19% -$596K 0.81% 44
2023
Q2
$3.34M Sell
91,034
-4,649
-5% -$181K 0.84% 37
2023
Q1
$3.9M Hold
95,683
1.02% 28
2022
Q4
$4.9M Buy
95,683
+7,231
+8% +$347K 1.26% 22
2022
Q3
$3.87M Buy
88,452
+1,290
+1% +$62.7K 1.15% 28
2022
Q2
$4.57M Buy
87,162
+487
+0.6% +$24.8K 1.31% 23
2022
Q1
$4.49M Buy
86,675
+181
+0.2% +$9.39K 1.12% 25
2021
Q4
$5.11M Buy
86,494
+53
+0.1% +$2.63K 1.24% 25
2021
Q3
$3.72M Hold
86,441
1% 35
2021
Q2
$3.38M Buy
86,441
+6,956
+9% +$271K 0.89% 44
2021
Q1
$2.88M Buy
79,485
+1,863
+2% +$66.1K 0.82% 48
2020
Q4
$2.86M Sell
77,622
-4,192
-5% -$154K 0.93% 41
2020
Q3
$2.85M Hold
81,814
1.11% 26
2020
Q2
$2.54M Hold
81,814
1.01% 37
2020
Q1
$2.53M Sell
81,814
-2,692
-3% -$91.7K 1.18% 28
2019
Q4
$3.14M Buy
84,506
+2,106
+3% +$75K 1.04% 32
2019
Q3
$2.81M Buy
82,400
+106
+0.1% +$3.85K 1.04% 31
2019
Q2
$3.31M Buy
82,294
+6,969
+9% +$277K 1.19% 24
2019
Q1
$3.04M Buy
75,325
+25,243
+50% +$1.01M 1.22% 21
2018
Q4
$2.07M Buy
+50,082
New +$2.08M 1.12% 21

Other funds holding PFE

Inlet Private Wealth's PFE Position: Q4 2025 in Review

Inlet Private Wealth sold out of Pfizer (PFE) in Q4 2025, closing a stake of 19,530 shares — an estimated $498K sold.

Inlet Private Wealth first reported a position in PFE in Q4 2018 and held it in 28 quarters. The position peaked at $5.11M in Q4 2021. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Inlet Private Wealth reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Inlet Private Wealth sold 19,530 Pfizer shares in Q4 2025, an estimated $498K.
  • Inlet Private Wealth first reported a position in Pfizer in Q4 2018 and held it in 28 quarters.
  • Inlet Private Wealth's Pfizer position peaked at $5.11M in Q4 2021.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Inlet Private Wealth's 13F filing for Q4 2025, filed 21 Jan 2026.